V V Kakkar. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAnticoagulants/administration & dosageAnticoagulants/therapeutic useAspirin/administration & dosageAspirin/therapeutic useDextrans/administration & dosageDextrans/therapeutic useDipyridamole/administration & dosageDipyridamole/therapeutic useFemaleFibrinogenHeparin/administration & dosageHeparin/therapeutic useHumansInfusions, ParenteralInjections, SubcutaneousIodine RadioisotopesMalePhlebographyPlethysmography, ImpedancePostoperative Complications/prevention & controlThrombophlebitis/diagnosisThrombophlebitis/diagnostic imagingThrombophlebitis/prevention & controlUltrasonographyVenous Insufficiency/prevention & controlWounds and Injuries/complications
Substances: See more » AnticoagulantsDextransIodine RadioisotopesDipyridamoleFibrinogenHeparinAspirin
Year: 1975 PMID: 1088937 DOI: 10.1161/01.cir.51.1.8
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690